Predictors of impaired antibody response after <scp>SARS‐CoV</scp> ‐2 <scp>mRNA</scp> vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study-Reference-Cited by-同舟云学术

Predictors of impaired antibody response after SARS‐CoV ‐2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study

Published:2022-10-31 Issue:1 Volume:98 Page:102-111
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Mori Yasuo¹,Uchida Naoyuki²^ORCID,Harada Takuya¹^ORCID,Katayama Yuta³,Wake Atsushi⁴,Iwasaki Hiromi⁵,Eto Tetsuya⁶,Morishige Satoshi⁷,Fujisaki Tomoaki⁸,Ito Yoshikiyo⁹,Kamimura Tomohiko¹⁰,Takahashi Tsutomu¹¹^ORCID,Imamura Yutaka¹²,Tanimoto Kazushi¹³,Ishitsuka Kenji¹⁴,Sugita Junichi¹⁵,Kawano Noriaki¹⁶,Tanimoto Kazuki¹⁷,Yoshimoto Goichi¹⁸,Choi Ilseung¹⁹,Hidaka Tomonori²⁰,Ogawa Ryosuke²¹,Takamatsu Yasushi²²,Miyamoto Toshihiro¹²³,Akashi Koichi¹,Nagafuji Koji⁷^ORCID

Affiliation:

1. Department of Medicine and Biosystemic Science Kyushu University Graduate School of Medical Science Fukuoka Japan

2. Department of Hematology Toranomon Hospital Tokyo Japan

3. Department of Hematology Hiroshima Red Cross Hospital and Atomic‐Bomb Survivors Hospital Hiroshima Japan

4. Department of Hematology Toranomon Hospital Kajigaya Kawasaki Japan

5. Departments of Hematology National Hospital Organization, Kyushu Medical Center Fukuoka Japan

6. Department of Hematology Hamanomachi Hospital Fukuoka Japan

7. Division of Hematology and Oncology, Department of Medicine Kurume University School of Medicine Kurume Japan

8. Department of Internal Medicine Matsuyama Red Cross Hospital Matsuyama Japan

9. Department of Hematology Imamura General Hospital Kagoshima Japan

10. Department of Hematology Harasanshin Hospital Fukuoka Japan

11. Department of Hematology Shimane University Hospital Izumo Japan

12. Division of Hematology St. Mary's Hospital Kurume Japan

13. Department of Hematology, Clinical Immunology, and Infectious Diseases Ehime University Graduate School of Medicine Ehime Japan

14. Department of Hematology and Rheumatology Kagoshima University Hospital Kagoshima Japan

15. Department of Hematology Hokkaido University Hospital Sapporo Japan

16. Department of Internal Medicine Miyazaki Prefectural Miyazaki Hospital Miyazaki Japan

17. Department of Hematology Fukuoka Red Cross Hospital Fukuoka Japan

18. Department of Hematology Saga‐Ken Medical Center Koseikan Saga Japan

19. Department of Hematology National Hospital Organization Kyushu Cancer Center Fukuoka Japan

20. Department of Gastroenterology and Hematology, Faculty of Medicine University of Miyazaki Miyazaki Japan

21. Department of Hematology and Oncology JCHO Kyushu Hospital Fukuoka Japan

22. Division of Medical Oncology, Hematology and Infectious Diseases, Faculty of Medicine Fukuoka University Fukuoka Japan

23. Division of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences Kanazawa University Kanazawa Japan

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26769

Reference45 articles.

1. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

2. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

3. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey

4. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

5. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101);2024-01-25

2. Impact of a third dose of anti-SARS-CoV-2 vaccine in hematopoietic cell transplant recipients: A Japanese multicenter observational study;Vaccine;2023-11

3. Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipients;Frontiers in Immunology;2023-10-24

4. Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients—A Retrospective Single-Center Analysis;Vaccines;2023-09-28

5. Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis;Blood Advances;2023-09-18